These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 35493741)
1. Impacts of MicroRNAs Induced by the Gut Microbiome on Regulating the Development of Colorectal Cancer. Xing J; Liao Y; Zhang H; Zhang W; Zhang Z; Zhang J; Wang D; Tang D Front Cell Infect Microbiol; 2022; 12():804689. PubMed ID: 35493741 [TBL] [Abstract][Full Text] [Related]
2. [Gut microbiota: What impact on colorectal carcinogenesis and treatment?]. Bruneau A; Baylatry MT; Joly AC; Sokol H Bull Cancer; 2018 Jan; 105(1):70-80. PubMed ID: 29217301 [TBL] [Abstract][Full Text] [Related]
3. Gut microbiome associated with APC gene mutation in patients with intestinal adenomatous polyps. Liang S; Mao Y; Liao M; Xu Y; Chen Y; Huang X; Wei C; Wu C; Wang Q; Pan X; Tang W Int J Biol Sci; 2020; 16(1):135-146. PubMed ID: 31892851 [No Abstract] [Full Text] [Related]
4. Effects of Long Non-Coding RNAs Induced by the Gut Microbiome on Regulating the Development of Colorectal Cancer. Fan S; Xing J; Jiang Z; Zhang Z; Zhang H; Wang D; Tang D Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497293 [TBL] [Abstract][Full Text] [Related]
5. Strategies for the treatment of colorectal cancer caused by gut microbiota. de Souza JB; Brelaz-de-Castro MCA; Cavalcanti IMF Life Sci; 2022 Feb; 290():120202. PubMed ID: 34896161 [TBL] [Abstract][Full Text] [Related]
6. Interaction between Host MicroRNAs and the Gut Microbiota in Colorectal Cancer. Yuan C; Burns MB; Subramanian S; Blekhman R mSystems; 2018; 3(3):. PubMed ID: 29795787 [TBL] [Abstract][Full Text] [Related]
7. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer. Qu R; Zhang Y; Ma Y; Zhou X; Sun L; Jiang C; Zhang Z; Fu W Adv Sci (Weinh); 2023 Aug; 10(23):e2205563. PubMed ID: 37263983 [TBL] [Abstract][Full Text] [Related]
9. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Wong SH; Yu J Nat Rev Gastroenterol Hepatol; 2019 Nov; 16(11):690-704. PubMed ID: 31554963 [TBL] [Abstract][Full Text] [Related]
10. Exploring the Role of Gut Microbiome in Colon Cancer. Chattopadhyay I; Dhar R; Pethusamy K; Seethy A; Srivastava T; Sah R; Sharma J; Karmakar S Appl Biochem Biotechnol; 2021 Jun; 193(6):1780-1799. PubMed ID: 33492552 [TBL] [Abstract][Full Text] [Related]
11. Gut microbiota, inflammatory bowel disease and colorectal cancer. Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114 [TBL] [Abstract][Full Text] [Related]
12. miRNA-Microbiota Interaction in Gut Homeostasis and Colorectal Cancer. Dong J; Tai JW; Lu LF Trends Cancer; 2019 Nov; 5(11):666-669. PubMed ID: 31735285 [TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer: the facts in the case of the microbiota. Clay SL; Fonseca-Pereira D; Garrett WS J Clin Invest; 2022 Feb; 132(4):. PubMed ID: 35166235 [TBL] [Abstract][Full Text] [Related]
14. The roles of the gut microbiota-miRNA interaction in the host pathophysiology. Li M; Chen WD; Wang YD Mol Med; 2020 Nov; 26(1):101. PubMed ID: 33160314 [TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer and gut microbiota studies in China. Wang Z; Dan W; Zhang N; Fang J; Yang Y Gut Microbes; 2023; 15(1):2236364. PubMed ID: 37482657 [TBL] [Abstract][Full Text] [Related]
16. Cross-Kingdom Interaction of miRNAs and Gut Microbiota with Non-Invasive Diagnostic and Therapeutic Implications in Colorectal Cancer. Pös O; Styk J; Buglyó G; Zeman M; Lukyova L; Bernatova K; Hrckova Turnova E; Rendek T; Csók Á; Repiska V; Nagy B; Szemes T Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445698 [TBL] [Abstract][Full Text] [Related]
17. Could gut microbiota serve as prognostic biomarker associated with colorectal cancer patients' survival? A pilot study on relevant mechanism. Wei Z; Cao S; Liu S; Yao Z; Sun T; Li Y; Li J; Zhang D; Zhou Y Oncotarget; 2016 Jul; 7(29):46158-46172. PubMed ID: 27323816 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of the NF-κB/HIF-1α signaling pathway in colorectal cancer by tyrosol: a gut microbiota-derived metabolite. Guo J; Meng F; Hu R; Chen L; Chang J; Zhao K; Ren H; Liu Z; Hu P; Wang G; Tai J J Immunother Cancer; 2024 Sep; 12(9):. PubMed ID: 39343509 [TBL] [Abstract][Full Text] [Related]
19. Gut microbiota-derived metabolites in CRC progression and causation. Dalal N; Jalandra R; Bayal N; Yadav AK; Harshulika ; Sharma M; Makharia GK; Kumar P; Singh R; Solanki PR; Kumar A J Cancer Res Clin Oncol; 2021 Nov; 147(11):3141-3155. PubMed ID: 34273006 [TBL] [Abstract][Full Text] [Related]
20. The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis. Conde-Pérez K; Aja-Macaya P; Buetas E; Trigo-Tasende N; Nasser-Ali M; Rumbo-Feal S; Nión P; Arribas EM; Estévez LS; Otero-Alén B; Noguera JF; Concha Á; Pardiñas-López S; Carda-Diéguez M; Gómez-Randulfe I; Martínez-Lago N; Ladra S; Aparicio LMA; Bou G; Mira Á; Vallejo JA; Poza M Mol Oncol; 2024 May; 18(5):1093-1122. PubMed ID: 38366793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]